Analyst Research: OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

21.48USD
26 Dec 2014
Price Change (% chg)

$0.56 (+2.68%)
Prev Close
$20.92
Open
$21.10
Day's High
$21.72
Day's Low
$20.91
Volume
34,605
Avg. Vol
49,351
52-wk High
$42.34
52-wk Low
$16.61

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - ONCOMED PHARMACEUTICALS INC (OMED-O) 5 Dec 2014 Thomson Reuters Stock Report 11 25.00
Wright Investors Service Comprehensive Report for Oncomed Pharmaceuticals Inc 4 Dec 2014 Wright Reports 54 75.00
OncoMed Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 28 Nov 2014 Reuters Investment Profile 12 20.00
Value Graph: ONCOMED PHARMA -- OMED 27 Nov 2014 Ford Investor Services, Inc. 1 12.00
TheStreet.com Ratings Stock Report For: ONCOMED PHARMACEUTICALS (OMED) 22 Nov 2014 TheStreet.com Ratings 5 10.00
ONCOMED PHARMA (OMED) Zacks Company Snapshot 21 Nov 2014 Zacks Investment Research Inc. 1 12.00
TheStreet.com Ratings Stock Report For: ONCOMED PHARMACEUTICALS (OMED) 15 Nov 2014 TheStreet.com Ratings 5 10.00
TheStreet.com Ratings Stock Report For: ONCOMED PHARMACEUTICALS (OMED) 8 Nov 2014 TheStreet.com Ratings 5 10.00
OMED.OQ - Event Transcript of OncoMed Pharmaceuticals Inc conference call, Nov. 04, 2014 / 4:30PM ET 4 Nov 2014 Thomson Reuters StreetEvents 12 75.00
 
Name Age Since Current Position

Paul Hastings

54 President, Chief Executive Officer and Board Member

Sunil Patel

42 2014 Chief Financial Officer, Senior Vice President - Corporate Development and Finance

John Lewicki

62 Executive Vice President, Chief Scientific Officer

Jakob Dupont

49 Senior Vice President and Chief Medical Officer

Austin Gurney

50 Senior Vice President, Molecular and Cellular Biology
Search Stocks